Medifast (MED) Management Meeting Reinforces Confidence - DA Davidson
Tweet Send to a Friend
DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating and $250.00 price target on Medifast (NYSE: MED) after spending ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


